PANNA is the name of the study of Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA). The purpose of the study is to collect pharmacokinetic data (PK curves) in pregnant HIV-infected women using newly developed antiretroviral agents.

Setting up a European network

The group of pharmacist David Burger (Radboud university medical center, The Netherlands) has set up a European network of centres that are willing and able to participate in this study.

This website gives information about the study, how physicians can include patients and how centres can participate in the PANNA study.